personal and social development of humankind. Changing behavior is the basis of treating eating disorders, obesity and different kinds of addictions such as drug, smoke and recently addiction like mobile
disease. The driving force for the development of dietary therapies is the lack of efficiency and/or the intolerable side effects of the drugs, coupled with the intrinsic appeal
Philippines had illicit drug problems. The country had about 1.8 million problem drug users with only 42 facilities accredited by the government. This study aimed to raise awareness ... programs to tailor fit the needs…
disease. The driving force for the development of dietary therapies is the lack of efficiency and/or the intolerable side effects of the drugs, coupled with the intrinsic appeal
Philippines had illicit drug problems. The country had about 1.8 million problem drug users with only 42 facilities accredited by the government. This study aimed to raise awareness ... programs to tailor fit the needs…
common causes of childhood blindness and vision impairment is retinopathy of prematurity (ROP). In developing countries with middle-income, such as Latin America, Eastern Europe, India and China ... factor in the…
healthy eyes with AOH and standards for eyes with OAG are not actually developed. Until recently, it was not even possible to determine which range of the true IOP norm ... traditional differential diagnostics. As a…
common causes of childhood blindness and vision impairment is retinopathy of prematurity (ROP). In developing countries with middle-income, such as Latin America, Eastern Europe, India and China ... factor in the…
healthy eyes with AOH and standards for eyes with OAG are not actually developed. Until recently, it was not even possible to determine which range of the true IOP norm ... traditional differential diagnostics. As a…
recent epidemic of resistance to these drugs in some parts of the world. The H58 clade which is responsible for the development of resistance, has been found globally, indicating
anti tubercular drugs in tuberculosis patients. It was prospective observational study 300 patients were included and were monitored for ADRs. Out of 300 patients, 110 (36.66%) developed ADR. The incidence ... patient…
Development of Pediatric Dosage Forms (PDF) is challenging and it’s mainly due to the differences in swallowing abilities, taste preferences, and dosage requirements of children. The most commonly prescribed ... young…
blood disorders develop will help cure these life threatening complications. Pharmacological treatment strategies for post-transplant blood disorders like tapering immunosuppressive therapy or replacing myelotoxic…
drug. Hence gastrointestinal (GI)solubility is an essential parameter in the development of a new drug. Much research has been done on this field aiming at increasing the kinetic
encountered a range of challenges. Of course, some of them are common with the developed industry. In order to bring together information on challenges of the pharmaceutical industry a comprehensive ... lowest level…
permeation of optimized microemulsion formulation showed 4.1 folds higher flux when compared with drug solution (21.08μg/cm2/h). Validation of the optimization study with 6 confirmatory runs indicated ... ability of…
metabolic syndrome early to make interventions to prevent the development of diabetes and/or cardiovascular disease. Statins are lipid-lowering drugs that considered as cornerstones of treatment in patients with…
study was intended to develop a copolymer based carrier system of drug Risedronate (RIS) for its effective bone delivery at the target site for the treatment of Osteoporosis (porous bone
skin to treat skin disease conditions or to alleviate symptoms. Developing a dermatology generic drug product involves many regulations and needs critical understanding of the test product as well ... clear pathway to…
Problem Statement: The Food and Drug Administration has historically made approval decisions for new devices without meaningful patient input. Individual patients experience effects of diseases and therapies differently…
multi-drug resistant strain and the extensively drug-resistant strain from different geographical locations collected from NCBI-SRA. An effective pipeline is developed to analyze and interpret mutations causing…
distractions can be grouped into 3 options: prompting diagnoses and treatment with anti-malaria drugs; eliminating the vector by different measures and prophylaxis-vaccination. By such measures, the burden ... realizing…
Introduction: The development of new drugs is a complex process, with only 0.027% of newly synthesized molecules being approved by regulatory agencies. Inadequate pharmacokinetic properties and toxicity are responsible…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.